Investor Presentation First Nine Months of 2023

125 Investor presentation First nine months of 2023 GLP-1 market share and market growth in Region China 160% 120% 80% 40% GLP-1 market growth and Novo Nordisk market share DKK billion 160% 120% 95% 94% 3 75% 80% 62% 40% 62.3% GLP-1 market size and growth ~62% Region China 0 4 2 0 -94% 74.6% 0% Aug 2020 -NN market share -Market growth (right axis) 0% Aug 2023 Aug 2022 Novo Nordisk Company A Others Aug 2023 Novo Nordisk Competitors NN share of growth NN growth (right axis) Source: IQVIA, Aug 2023, Value, MAT; Due to contractual obligations competitor names are not disclosed. Company A represents an actual company. NN: Novo Nordisk; Region China covers Mainland China, Taiwan, and Hong Kong; Market values are based on the list prices

View entire presentation